There are 2137 resources available
497P - Investigating the potential relationship between KMT2C/KMT2D mutations and immune checkpoint inhibitor (ICI) in colorectal cancer (CRC)
Presenter: chengli miao
Session: E-Poster Display
Resources:
Abstract
498P - Differences in tumor immune microenvironment and clinical outcomes between right and left colon cancer
Presenter: Zhengqi Wen
Session: E-Poster Display
Resources:
Abstract
499P - Heterogeneity in the immune inflamed biomarkers of MSS and MSI colorectal cancer
Presenter: Iosune Baraibar Argota
Session: E-Poster Display
Resources:
Abstract
500P - Local lymphatic reaction in colorectal cancer: The relationship to patient survival, systemic inflammatory markers, MSI and KRAS mutations to tumour
Presenter: Yifei Ma
Session: E-Poster Display
Resources:
Abstract
501P - Spatial immunology in colorectal liver metastases
Presenter: Gemma Garcia-Vicién
Session: E-Poster Display
Resources:
Abstract
502P - Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes
Presenter: James Lam
Session: E-Poster Display
Resources:
Abstract
503P - The Screening and COnsensus based on Practices and Evidence (SCOPE) survey: Treatment goals and practice patterns in third- and fourth-line metastatic colorectal cancer
Presenter: Gerald Prager
Session: E-Poster Display
Resources:
Abstract
504P - Primary tumour location impacts oncological outcome of patients with resected colorectal liver metastases
Presenter: Vilma Pacheco-Barcia
Session: E-Poster Display
Resources:
Abstract
505P - Prediction of mortality in metastatic colorectal cancer in a real-life population based on treatment modality and accompanying clinical parameters
Presenter: Holger Rumpold
Session: E-Poster Display
Resources:
Abstract
506P - Relation of metastasis localization, survival outcome and treatment modality in metastatic colorectal cancer
Presenter: Patrick Kirchweger
Session: E-Poster Display
Resources:
Abstract